{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/42996"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/42996","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Studies towards the synthesis of 3,5-dimethylorsellinic acid meroterpenoids","abstract":"3,5-Dimethylorsellinic acid (DMOA)-derived meroterpenoids are a rich, structurally diverse family of natural products with a range of biological activities. Several total syntheses have been completed to date, but no broad synthetic scheme has been developed. In order to address this problem, a synthetic platform to produce 3,5-dimethylorsellinic acid (DMOA) meroterpenoids has been developed. Using a biomimetic strategy, DMOA was directly coupled to farnesyl electrophiles using a regioselective, base-mediated alkylative dearomatization strategy. Further chemical reactions including methylation and polyene cyclization resulted in the production of five unique tetracyclic DMOA-derived meroterpenoids. An understanding of the stereochemical outcome was explained via computational and experimental methods. Further development of the platform involved incubation of synthetic farnesyl-DMOA coupling substrates with terpene cyclase enzymes in a collaborative effort to produce novel chemoenzymatic DMOA-derived meroterpenoids. DMOA and DMOA methyl ester were employed in this strategy with multiple farnesyl derivatives to create both natural and non-natural DMOA-derived products. After both chemical and chemoenzymatic studies were completed, additional studies were initiated to synthesize the specific meroterpenoid target asperterpene A, an inhibitor of the B-secretase (BACE1) enzyme. A strategy involving direct alkylation of the decalin core using DMOA will be described, as well as a synthetic strategy from (-)-carvone.","abstract_html":"3,5-Dimethylorsellinic acid (DMOA)-derived meroterpenoids are a rich, structurally diverse family of natural products with a range of biological activities. Several total syntheses have been completed to date, but no broad synthetic scheme has been developed. In order to address this problem, a synthetic platform to produce 3,5-dimethylorsellinic acid (DMOA) meroterpenoids has been developed. Using a biomimetic strategy, DMOA was directly coupled to farnesyl electrophiles using a regioselective, base-mediated alkylative dearomatization strategy. Further chemical reactions including methylation and polyene cyclization resulted in the production of five unique tetracyclic DMOA-derived meroterpenoids. An understanding of the stereochemical outcome was explained via computational and experimental methods. Further development of the platform involved incubation of synthetic farnesyl-DMOA coupling substrates with terpene cyclase enzymes in a collaborative effort to produce novel chemoenzymatic DMOA-derived meroterpenoids. DMOA and DMOA methyl ester were employed in this strategy with multiple farnesyl derivatives to create both natural and non-natural DMOA-derived products. After both chemical and chemoenzymatic studies were completed, additional studies were initiated to synthesize the specific meroterpenoid target asperterpene A, an inhibitor of the B-secretase (BACE1) enzyme. A strategy involving direct alkylation of the decalin core using DMOA will be described, as well as a synthetic strategy from (-)-carvone.","abstract_has_math":false,"creators":["Powers, Zachary"],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":[],"advisors":["Porco, Jr., John A."],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021","date_published":"2021","updated_at":"2026-11-19T02:41:40Z","subjects":["Organic chemistry"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/42996","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/42996","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F42996","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Porco, Jr., John A."]},{"key":"dc:creator","label":"Author","values":["Powers, Zachary"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-09-13T14:15:54Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2023-09-10T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2021"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2021-09-10T20:08:12Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Organic chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/42996"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["3,5-Dimethylorsellinic acid (DMOA)-derived meroterpenoids are a rich, structurally diverse family of natural products with a range of biological activities. Several total syntheses have been completed to date, but no broad synthetic scheme has been developed. In order to address this problem, a synthetic platform to produce 3,5-dimethylorsellinic acid (DMOA) meroterpenoids has been developed. Using a biomimetic strategy, DMOA was directly coupled to farnesyl electrophiles using a regioselective, base-mediated alkylative dearomatization strategy. Further chemical reactions including methylation and polyene cyclization resulted in the production of five unique tetracyclic DMOA-derived meroterpenoids. An understanding of the stereochemical outcome was explained via computational and experimental methods. Further development of the platform involved incubation of synthetic farnesyl-DMOA coupling substrates with terpene cyclase enzymes in a collaborative effort to produce novel chemoenzymatic DMOA-derived meroterpenoids. DMOA and DMOA methyl ester were employed in this strategy with multiple farnesyl derivatives to create both natural and non-natural DMOA-derived products. After both chemical and chemoenzymatic studies were completed, additional studies were initiated to synthesize the specific meroterpenoid target asperterpene A, an inhibitor of the B-secretase (BACE1) enzyme. A strategy involving direct alkylation of the decalin core using DMOA will be described, as well as a synthetic strategy from (-)-carvone."]},{"key":"dc:title","label":"Title","values":["Studies towards the synthesis of 3,5-dimethylorsellinic acid meroterpenoids"]}]}],"canonical_facts":{"dc:contributor.advisor":["Porco, Jr., John A."],"dc:creator":["Powers, Zachary"],"dc:date.accessioned":["2021-09-13T14:15:54Z"],"dc:date.embargo":["2023-09-10T00:00:00Z"],"dc:date.issued":["2021"],"dc:date.updated":["2021-09-10T20:08:12Z"],"dc:description.abstract":["3,5-Dimethylorsellinic acid (DMOA)-derived meroterpenoids are a rich, structurally diverse family of natural products with a range of biological activities. Several total syntheses have been completed to date, but no broad synthetic scheme has been developed. In order to address this problem, a synthetic platform to produce 3,5-dimethylorsellinic acid (DMOA) meroterpenoids has been developed. Using a biomimetic strategy, DMOA was directly coupled to farnesyl electrophiles using a regioselective, base-mediated alkylative dearomatization strategy. Further chemical reactions including methylation and polyene cyclization resulted in the production of five unique tetracyclic DMOA-derived meroterpenoids. An understanding of the stereochemical outcome was explained via computational and experimental methods. Further development of the platform involved incubation of synthetic farnesyl-DMOA coupling substrates with terpene cyclase enzymes in a collaborative effort to produce novel chemoenzymatic DMOA-derived meroterpenoids. DMOA and DMOA methyl ester were employed in this strategy with multiple farnesyl derivatives to create both natural and non-natural DMOA-derived products. After both chemical and chemoenzymatic studies were completed, additional studies were initiated to synthesize the specific meroterpenoid target asperterpene A, an inhibitor of the B-secretase (BACE1) enzyme. A strategy involving direct alkylation of the decalin core using DMOA will be described, as well as a synthetic strategy from (-)-carvone."],"dc:identifier.uri":["https://hdl.handle.net/2144/42996"],"dc:language.iso":["en_US"],"dc:subject":["Organic chemistry"],"dc:title":["Studies towards the synthesis of 3,5-dimethylorsellinic acid meroterpenoids"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:40Z"}